Sanofi

Pharmaceuticals
France
Earnings Per Share Growth (%)-1.52%
Cost of Goods Sold (US$ Millions)$11,893
Current Liabilities (US$ Millions)$18,326
Total Assets (US$ Millions)$27,152
Long Term Debt$14,288
Return on Equity7.64%
Revenue (US$ Millions)$37,971
Total Company Assets$111,449
Revenue Growth (%)2.20%
Net Income (US$ Millions)$4,669
Earnings Per Share (US$)($1.52)
Total Equity (US$ Millions)$63,228
Profit Margin (%)12.30%
Debt To Equity Ratio (%)0.23%
Inventory Turnover$7,097